Drug Topics
JANUARY 21, 2025
Kurt Proctor, BS Pharm, PhD, CCHS, President of the NCPA Innovation Center, discussed his organizations efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.
PharmaVoice
JANUARY 21, 2025
Accessia Health helps ease the burden of managing a rare disease or chronic condition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 21, 2025
The approval makes Johnson and Johnsons esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.
Pharmacy Times
JANUARY 21, 2025
Esketamine targets glutamate, the most abundant neurotransmitters in the brain.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JANUARY 21, 2025
For adults with obesity but no diabetes diagnosis, researchers searched for the key factors leading to semaglutide initiation.
Pharmaceutical Technology
JANUARY 21, 2025
Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
JANUARY 21, 2025
Early planning and market research are crucial in an era of rising cost pressures.
Pharmacy Times
JANUARY 21, 2025
At the start of 2025, 590 drug prices changed, with only 7 drugs seeing decreases in wholesale acquisition costs (WAC).
PharmaVoice
JANUARY 21, 2025
Novel drug approvals have set the stage for more breakthroughs in pharma.
Fierce Healthcare
JANUARY 21, 2025
Fierce Healthcare is tracking workforce changes across healthcare in 2025. Stick with this tracker for the latest updates, and reach out to the team with any layoff news. | Stick with this tracker for the latest layoff and workforce updates from across healthcare.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JANUARY 21, 2025
With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility and potential.
pharmaphorum
JANUARY 21, 2025
Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market
Fierce Healthcare
JANUARY 21, 2025
The pharmacy chain dispensed dangerous and excessive quantities," early refills of opioids and prescriptions for the especially dangerous and abused combination of drugs known as the trinity," the DOJ said Friday.
pharmaphorum
JANUARY 21, 2025
Odyssey and Sionna have filed to carry out IPOs on the Nasdaq, following after Metsera and Maze which filed earlier in January
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JANUARY 21, 2025
Following its massive $275 million series F funding round, health tech company Innovaccer announced its purchase of actuarial intelligence company Humbi AI.
pharmaphorum
JANUARY 21, 2025
The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.
Outsourcing Pharma
JANUARY 21, 2025
Australian CDMOs, BioCina and NovaCina, have merged in a move to pool their biologic and small molecule production expertise and infrastructure.
Pharmig
JANUARY 21, 2025
The New Year is an exciting time, but returning back to work can be tough. Learn how pharmaceutical microbiologists can get back into the flow online here. The post How to Embrace the New Year at Work appeared first on Pharmig.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 21, 2025
Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
pharmaphorum
JANUARY 21, 2025
GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies Jemperli and Rybrevant in the EU
Pharmacy Times
JANUARY 21, 2025
The international cohort study evaluated the safety, efficacy of BCMA-targeting agents ciltacabtagene autoleucel and idecabtagene vicleucel.
Outsourcing Pharma
JANUARY 21, 2025
Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects the drug is known for.
Pharmacy Times
JANUARY 21, 2025
KN026 is a humanized bispecific antibody that targets and binds to HER2 proteins on the surface of cancer cells.
Pharmaceutical Technology
JANUARY 21, 2025
Panellists at the World Economic Forum 2025 Davos meeting discussed how artificial intelligence (AI) could help close the gap in womens health research.
Pharmacy Times
JANUARY 21, 2025
Multiple treatments have been approved by regulators for the treatment of hemophilia A and B, giving pharmacists options for their patients.
Pharmaceutical Technology
JANUARY 21, 2025
Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in Europe.
Pharmacy Times
JANUARY 21, 2025
The study found that internalizing and externalizing factors, brain maturation, and decreasing volumes of brain regions were linked to eating disorders.
Pharmaceutical Technology
JANUARY 21, 2025
The Lazcluze plus Rybrevant combination could challenge AstraZenecas standard-of-care Tagrisso in non-small cell lung cancer (NSCLC).
Pharmacy Times
JANUARY 21, 2025
A series of patient cases demonstrates the potential harm that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) may face when transitioning from intravenous immunoglobulin (IVIG) to FcRn therapy.
Pharmaceutical Commerce
JANUARY 21, 2025
The latest AARP report concludes that plan members who hit this amount are expected to see savings, even when premiums are considered.
Pharmacy Times
JANUARY 21, 2025
Investigators assessed fixed-duration venetoclax plus acalabrutinib with or without obinutuzumab vs chemoimmunotherapy.
Pharmaceutical Technology
JANUARY 21, 2025
Afrigen Biologics has secured a $6.2m grant from CEPI to develop the first mRNA-based vaccine against Rift Valley fever.
Pharmacy Times
JANUARY 21, 2025
In addition, pharmacists can screen for potential contraindications and drug-drug interactions.
Expert insights. Personalized for you.
281 
Let's personalize your content